The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy

INTRODUCTION: External beam radiotherapy is a treatment option for clinically localised prostate cancer; however, some 15% of patients will undergo treatment failure within 5 years. The objective was to compare the Cancer of the Prostate Risk Assessment (CAPRA) score (based on the clinical-pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Salazar, Anibal, Guzman, Eghon, Orrego, Shenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289617/
https://www.ncbi.nlm.nih.gov/pubmed/32565895
http://dx.doi.org/10.3332/ecancer.2020.1042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289617/
https://www.ncbi.nlm.nih.gov/pubmed/32565895
http://dx.doi.org/10.3332/ecancer.2020.1042

Ejemplares similares